2004 to Be a Pivotal Year of Long Island-Based Osi Pharmaceuticals
Long Island Business News › January 17, 2006
Linked as:
Summary
Monday, Aug. 19, 2002, was the kind of day that would test the mettle of any investor-relations executive.
At OSI Pharmaceuticals Inc., the poster child of Long Island biotechnology, the telephone of Kathy Galante was ringing nonstop.See the full content of this document
Extract
2004 to Be a Pivotal Year of Long Island-Based Osi Pharmaceuticals
By day's end, a stampede of investors had bolted from OSI, sending the stock on a dizzying freefall from $32.78 the previous Friday to $14.05 by the closing bell and cutting the company's market capitalization in half.
Oddly enough, the impetus behind that stampede was news not about OSI but about a competitor, London-based AstraZeneca plc.That day, AstraZe...See the full content of this document
Sponsored links
